| David M Ozog, MD | |
|
3031 W Grand Blvd, Detroit, MI 48202-3046 | |
| (313) 916-2454 | |
| Not Available |
| Full Name | David M Ozog |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 24 Years |
| Location | 3031 W Grand Blvd, Detroit, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083792113 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Hospital | Detroit, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Henry Ford Medical Group | 0547178311 | 2095 |
News Archive
A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA - so-called epigenetic changes - to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute.
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
Some local news outlets report on their rankings in a new federal report. In the meantime, Minnesota researchers examine the insurance status of children.
Study shows lipid nanoparticle-based siRNA is potent in suppressing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – in cells as well as in mice models.
› Verified 6 days ago
| Entity Name | Henry Ford Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730252339 PECOS PAC ID: 0547178311 Enrollment ID: O20031111000124 |
News Archive
A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA - so-called epigenetic changes - to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute.
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
Some local news outlets report on their rankings in a new federal report. In the meantime, Minnesota researchers examine the insurance status of children.
Study shows lipid nanoparticle-based siRNA is potent in suppressing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – in cells as well as in mice models.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David M Ozog, MD 3031 W Grand Blvd, Detroit, MI 48202-3046 Ph: (313) 916-2454 | David M Ozog, MD 3031 W Grand Blvd, Detroit, MI 48202-3046 Ph: (313) 916-2454 |
News Archive
A difficult-to-treat form of childhood leukemia relies on changes in the structure of DNA - so-called epigenetic changes - to wreak genomic havoc within white blood cells, according to one of two studies conducted by a research team at Children's Hospital Boston and Dana-Farber Cancer Institute.
Scientists at the Gladstone Institute of Cardiovascular Disease (GICD) and Stanford University School of Medicine will collaborate in a new consortium funded by the National Heart, Lung and Blood Institute (NHLBI) to develop stem cell and regenerative medicine therapies. GICD investigators, led by GICD Director Deepak Srivastava, MD, will collaborate with a Stanford team led by Robert Robbins, MD, professor and chair of cardiothoracic surgery, to investigate how to use induced pluripotent stem cells, or iPS cells, to repair damaged heart muscle.
A study published in the March 2013 issue of the Journal of the American Academy of Child and Adolescent Psychiatry found that 9 out of 10 young children with moderate to severe attention-deficit/hyperactivity disorder (ADHD) continue to experience serious to severe symptoms and impairment long after their original diagnoses, and in many cases, despite treatment.
Some local news outlets report on their rankings in a new federal report. In the meantime, Minnesota researchers examine the insurance status of children.
Study shows lipid nanoparticle-based siRNA is potent in suppressing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the causative agent of coronavirus disease 2019 (COVID-19) – in cells as well as in mice models.
› Verified 6 days ago
Dr. Laurie Linden Kohen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2171 | |
James A Brown, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 22151 Moross, Suite 234, Detroit, MI 48236 Phone: 313-885-5110 Fax: 313-885-8755 | |
Dr. Emily L. Keimig, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 | |
Dr. Alison Tisack Boucher, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2151 | |
Marsha L. Chaffins, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 3031 West Grand Blvd., Detroit, MI 48202 Phone: 313-916-2454 | |
Dr. Snehal R Desai, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3031 W Grand Blvd, Suite 800, Detroit, MI 48202 Phone: 313-916-2171 |